STOCK TITAN
  1. Home
  2. Sec-filings
  3. GSK
  4. [6-K] GSK plc American Current Report (Foreign Issuer)

[6-K] GSK plc American Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock GSK logo
GSK PLC

NYSE:GSK

GSK Rankings

#219 Ranked by Market Cap
#676 Ranked by Dividends

GSK Latest News

Jul 17, 2025
US FDA Approves GSK’s SHINGRIX in a Prefilled Syringe Presentation
Jul 10, 2025
GSK begins shipping influenza vaccine doses for the 2025-26 flu season
Jun 24, 2025
FDA approves Benlysta (belimumab) Autoinjector for children with active lupus nephritis
Jun 16, 2025
GSK announces the Linked by Lupus: Optimal Care Initiative to help support individuals with lupus in the US
Jun 2, 2025
Theravance Biopharma, Inc. Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225 Million

GSK Latest SEC Filings

Jul 18, 2025
[6-K] GSK plc American Current Report (Foreign Issuer)
Jul 18, 2025
[6-K] GSK plc American Current Report (Foreign Issuer)
Jul 17, 2025
[6-K] GSK plc American Current Report (Foreign Issuer)
Jul 17, 2025
[6-K] GSK plc American Current Report (Foreign Issuer)
Jul 16, 2025
[6-K] GSK plc American Current Report (Foreign Issuer)

GSK Stock Data

79.96B
2.04B
0.06%
17.05%
0.91%
Drug Manufacturers - General
Healthcare
Link
United Kingdom
England